Full Length Research Paper
References
|
Akintunde AA, Ayodele E, Akinwusi OP, Opadijo GO (2010). Dyslipidemia Among Newly Diagnosed Hypertensives: Pattern and Clinical Correlates. Journal of the National Medical Association 102:403-407. Crossref |
||||
|
Albucher JF, Ferrieres J, Ruidavets JB, Guiraud-Chaumeil B, Perret BP, Chollet F (2000). Serum lipids in young patients with ischaemic stroke: a case-control study. Journal of Neurology, Neurosurgery and Psychiatry 69(1):29-33. Crossref |
||||
| ÄŒaparević Z, Kostić N, Ćelić V, Ćosić Z, Marina Ä, Ilić S, PenÄić B (2009). Effects of acute exercise on atherogenic lipids in untreated mild hypertensive patients. Vojnosanitetski pregled 66(4):313-318. | ||||
|
Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR Jr, Liu K (2003). Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA 290(23):3092-3100. Crossref |
||||
|
Choi HK, Ford ES (2007). Prevalence of the metabolic syndrome in individuals with hyperuricemia. The American Journal of Medicine 120(5):442-447. Crossref |
||||
| Choudhury KN, Mainuddin AKM, Wahidzzaman M, Islam SMS (2014). Serum lipid profile and its association with hypertension in Bangladesh. Vascular Health and Risk Management 10:327-332. | ||||
|
Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M (2004). Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4(1):1-9. Crossref |
||||
|
Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G (2000). Effect of exercise on coronary endothelial function in patients with coronary artery disease. New England Journal of Medicine 342(7):454-460. Crossref |
||||
|
Iloh GP, Amadi AN, Njoku PU, Ofoedu JN, Awa-Madu J (2012). The magnitude of abdominal adiposity and atherogenic dyslipidemia among geriatric Nigerians with arterial hypertension in a rural hospital in South eastern Nigeria. Nigerian Journal of Clinical Practice 15:462-468. Crossref |
||||
|
Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP (2014). National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. Journal of clinical lipidology 8:473-488. Crossref |
||||
|
Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S (2007). Risk factors for early myocardial infarc¬tion in South Asians compared with individuals in other countries. JAMA 297(3):286-294. Crossref |
||||
|
Kannel WB (2000). Fifty years of Framingham study contributions to understanding hypertension. Journal of human hypertension 14:83-90. Crossref |
||||
|
Lu W, Song K, Wang Y, Zhang Q, Li W, Jiao H, Wang G, Huang G (2012). Relationship between serum uric acid and metabolic syndrome: an analysis by structural equation modeling. Journal of Clinical Lipidology 6(2):159-167. Crossref |
||||
|
Luo JY, Ma YT, Yu ZX, Yang YN, Xie X, Ma X, Liu F, Li XM, Chen BD (2014). Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey. Lipids in Health and Disease 13:4. Crossref |
||||
|
Marchi-Alves LM, Rigotti AR, Nogueira MS, Cesarino CB, Godoy SD (2012). Metabolic syndrome components in arterial hypertension. Revista da Escola de Enfermagem da USP 46:1349-1354. Crossref |
||||
|
Mora S, Glynn RJ, Ridker PM (2013). High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation 128(11):1189-97. Crossref |
||||
| National Cholesterol Education Program (NCEP) (2002). The third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143-421. | ||||
|
O'meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST (2004). Ethnic and sex differences in the prevalence, Treatment, and control of dyslipidemia among Hypertensive adults in the genoa study. Archives of Internal Medicine 164:1313-1318. Crossref |
||||
|
Oparil S, Zaman MA, Calhoun DA (2003). Pathogenesis of hypertension. Annals of Internal Medicine 139(9):761-776. Crossref |
||||
|
Osuji CU, Omejua EG (2012). Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients. Indian Indian Journal of Endocrinology and Metabolism 16(Suppl1):S104. Crossref |
||||
|
Papavasileiou MV, Karamanou AG, Kalogeropoulos P, Moustakas G, Patsianis S, Pittaras A (2016). Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients. Journal of Human Hypertension 30:414-417. Crossref |
||||
|
Peng TC, Wang CC, Kao TW, Chan JY, Yang YH, Chang YW, Chen WL (2015). Relationship between Hyperuricemia and Lipid Profiles in US Adults. BioMed Research International, 2015:127596. Crossref |
||||
| Pramiladevi R, Gooranavar SM, Biradar SB, Baragundi MC, Kora SA, Narayan M (2011). Study of lipid profile in Hypertensive patients in rural Karnataka. Journal of Pharmaceutical and Biomedical Sciences 7(18):1-6. | ||||
|
Rader DJ (2002). High-density lipoproteins and atherosclerosis. American Journal of Cardiology 90(8):62-70 Crossref |
||||
|
Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF (2006). Cardiovascular disease in HIV infection. American Heart Journal 151(6):1147-1155. Crossref |
||||
|
Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN (2008). Uric acid and the development of metabolic syndrome in women and men. Metabolism-Clinical and Experimental 57(6):845-852. Crossref |
||||
|
Tachebele B, Abebe M, Addis Z, Mesfin N (2014). Metabolic syndrome among hypertensivepatients at University of Gondar Hospital, North West Ethiopia. BMC Cardiovascular Disorders 14(1):177. Crossref |
||||
|
Unniachan S, Bash LD, Khovidhunkit W, Sri T, Vicaldo E, Ambegaonkar M (2014). Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries. International Journal of Clinical Practice 68(8):1010-1019. Crossref |
||||
|
Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Memon L, Zeljkovic A, Bogavac-Stanojevic N, Spasic S (2009). High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis 203(1):236-242. Crossref |
||||
|
World Health Organization (WHO) (2016). Chronic diseases and health promotion: Stepwise approach to surveillance (STEPS). |
||||
|
Yu S, Guo X, Yang H, Zheng L, Sun Y (2015). Metabolic syndrome in hypertensive adults from rural Northeast China: an update. BMC Public Health 15:247. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
